AKIRA S ET AL: "The evidence for interleukin-6 as an autocrine growth factor in malignancy.", SEMINARS IN CANCER BIOLOGY FEB 1992, vol. 3, no. 1, February 1992 (1992-02-01), pages 17 - 26, ISSN: 1044-579X (B1)

ZANGARI MAURIZIO ET AL: "Immunomodulatory drugs in multiple myeloma.", EXPERT OPINION ON INVESTIGATIONAL DRUGS NOV 2005, vol. 14, no. 11, November 2005 (2005-11-01), pages 1411 - 1418, XP002713351, ISSN: 1744-7658, DOI: 10.1517/13543784.14.11.1411 (B1)

ANDO KATSUTOSHI ET AL: "Tocilizumab, a Proposed Therapy for the Cachexia of Interleukin6-Expressing Lung Cancer", PLOS ONE, vol. 9, no. 7, 10 July 2014 (2014-07-10), pages e102436, XP055784490, DOI: 10.1371/journal.pone.0102436 (B1)

ANNUAL REVIEW MEN'EKI, vol. 1999, 1999, pages 257 - 269, XP008169107 (B1)

BECKER Y: "Molecular immunological approaches to biotherapy of human cancers - A review, hypothesis and implications", ANTICANCER RESEARCH, INTERNATIONAL INSTITUTE OF ANTICANCER RESEARCH, GR, vol. 26, no. 2A, 1 March 2006 (2006-03-01), pages 1113 - 1134, XP008087034, ISSN: 0250-7005 (B1)

BLOOD 15 DEC 2007, vol. 110, no. 13, 15 December 2007 (2007-12-15), pages 4319 - 4330, ISSN: 0006-4971 (B1)

CHERYL A. ARMSTRONG ET AL: "Melanoma-Derived Interleukin 6 Inhibits In Vivo Melanoma Growth.", JOURNAL OF INVESTIGATIVE DERMATOLOGY, vol. 102, no. 3, 1 March 1994 (1994-03-01), pages 278 - 284, XP055080261, ISSN: 0022-202X, DOI: 10.1111/1523-1747.ep12371782 (B1)

DAI 68 KAI ANNUAL MEETING OF THE JAPAN CANCER ASSOCIATION, 31 August 2009 (2009-08-31), pages 286, XP008169109 (B1)

DATABASE MEDLINE [online] US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US; 1 August 2008 (2008-08-01), SEBBA ANTHONY: "Tocilizumab: the first interleukin-6-receptor inhibitor.", XP002713356, Database accession no. NLM18653811 (B1)

DATABASE MEDLINE [online] US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US; 15 December 2007 (2007-12-15), DULUC DOROTH�E ET AL: "Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells.", XP002713350, Database accession no. NLM17848619 (B1)

DATABASE MEDLINE [online] US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US; February 1992 (1992-02-01), AKIRA S ET AL: "The evidence for interleukin-6 as an autocrine growth factor in malignancy.", XP002713357, Database accession no. NLM1643291 (B1)

DATABASE MEDLINE [online] US NATIONAL LIBRARY OF MEDICINE (NLM), BETHESDA, MD, US; November 2005 (2005-11-01), ZANGARI MAURIZIO ET AL: "Immunomodulatory drugs in multiple myeloma.", Database accession no. NLM16255679 (B1)

DULUC DOROTH�E ET AL: "Tumor-associated leukemia inhibitory factor and IL-6 skew monocyte differentiation into tumor-associated macrophage-like cells.", BLOOD 15 DEC 2007, vol. 110, no. 13, 15 December 2007 (2007-12-15), pages 4319 - 4330, XP055475444, ISSN: 0006-4971, DOI: 10.1182/blood-2007-02-072587 (B1)

E. SUZUKI: "Gemcitabine Selectively Eliminates Splenic Gr-1+/CD11b+ Myeloid Suppressor Cells in Tumor-Bearing Animals and Enhances Antitumor Immune Activity", CLINICAL CANCER RESEARCH, vol. 11, no. 18, 15 September 2005 (2005-09-15), pages 6713 - 6721, XP055080337, ISSN: 1078-0432, DOI: 10.1158/1078-0432.CCR-05-0883 (B1)

EP-A1- 2 305 306 (B1)

EP-A1- 2 578 233 (B1)

F. CABILLIC ET AL: "Interleukin-6 and vascular endothelial growth factor release by renal cell carcinoma cells impedes lymphocyte?dendritic cell cross-talk", CLINICAL & EXPERIMENTAL IMMUNOLOGY, vol. 146, no. 3, 1 December 2006 (2006-12-01), pages 518 - 523, XP055080239, ISSN: 0009-9104, DOI: 10.1111/j.1365-2249.2006.03212.x (B1)

J. VINCENT ET AL: "5-Fluorouracil Selectively Kills Tumor-Associated Myeloid-Derived Suppressor Cells Resulting in Enhanced T Cell-Dependent Antitumor Immunity", CANCER RESEARCH, vol. 70, no. 8, 15 April 2010 (2010-04-15), pages 3052 - 3061, XP055080069, ISSN: 0008-5472, DOI: 10.1158/0008-5472.CAN-09-3690 (B1)

J.IMMNOL., vol. 154, no. 5, 1995, pages 2281 - 2290, XP055100942 (B1)

JP-A- 2010 527 615 (B1)

LANCASTER J.M. ET AL: "Identification of genes associated with ovarian cancer metastasis using microarray expression analysis", INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, vol. 16, no. 5, 1 September 2006 (2006-09-01), US, pages 1733 - 1745, XP055784486, ISSN: 1048-891X, DOI: 10.1111/j.1525-1438.2006.00660.x (B1)

LATULIPPE EVA ET AL: "Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, US, vol. 62, no. 15, 1 August 2002 (2002-08-01), pages 4499 - 4506, XP002507791, ISSN: 0008-5472 (B1)

OGATA TOSHIYUKI ET AL: "Early administration of IL-6RA does not prevent radiation-induced lung injury in mice", RADIATION ONCOLOGY, BIOMED CENTRAL LTD, LO, vol. 5, no. 1, 7 April 2010 (2010-04-07), pages 26, XP021081382, ISSN: 1748-717X, DOI: 10.1186/1748-717X-5-26 (B1)

PORGADOR ET AL: "INTERLEUKIN 6 GENE TRANSFECTION INTO LEWIS LUNG CARCINOMA TUMOR CELL SUPPRESSES THE MALIGNANT PHENOTYPE AND CONFERS IMMUNOTHERAPEUTIC COMPETENCE AGAINST PARENTAL METASTATIC CELLS", CANCER RESEARCH, AMERICAN ASSOCIATION FOR CANCER RESEARCH, US, vol. 52, 1 July 1992 (1992-07-01), pages 3679 - 3686, XP002104479, ISSN: 0008-5472 (B1)

R BELLOMO: "The cytokine network in the critically Ill.", ANAESTH INTENSIVE CARE, 20(3), 1 August 1992 (1992-08-01), pages 288 - 302, XP055490396, Retrieved from the Internet <URL:http://www.ncbi.nlm.nih.gov/pubmed/1524167> [retrieved on 20180705] (B1)

SACCHI A ET AL: "Treatment with monoclonal antibody to a Lewis lung carcinoma-associated antigen: different effects on primary tumor and its metastases", CANCER TREAT REP., vol. 69, no. 9, 1 January 1985 (1985-01-01), pages 985 - 991, XP055784480 (B1)

SEBBA ANTHONY: "Tocilizumab: the first interleukin-6-receptor inhibitor.", AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY : AJHP : OFFICIAL JOURNAL OF THE AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 01 AUG 2008, vol. 65, no. 15, 1 August 2008 (2008-08-01), pages 1413 - 1418, ISSN: 1535-2900 (B1)

SEMINARS IN CANCER BIOLOGY FEB 1992, vol. 3, no. 1, February 1992 (1992-02-01), pages 17 - 26, ISSN: 1044-579X (B1)

SLEEMAN J ET AL: "Cancer metastasis as a therapeutic target", EUROPEAN JOURNAL OF CANCER, ELSEVIER, AMSTERDAM NL, vol. 46, no. 7, 1 May 2010 (2010-05-01), pages 1177 - 1180, XP027027291, ISSN: 0959-8049, [retrieved on 20100320] (B1)

SOCIETY FOR FUNDAMENTAL CANCER IMMUNOLOGY, vol. 10TH, 2006, pages 49, XP008168592 (B1)

TANAKA ET AL: "The anti-human tumor effect and generation of human cytotoxic T cells in SCID mice given human peripheral blood lymphocytes by the in vivo transfer of the Interleukin-6 gene using adenovirus vector.", CANCER RESEARCH, vol. 57, no. 7, 1 April 1997 (1997-04-01), pages 1335 - 1343, XP055080260, ISSN: 0008-5472 (B1)

THOMAS R ULICH ET AL: "Intratracheal Injection of Endotoxin and Cytokines II. Interleukin-6 and Transforming Growth Factor Beta Inhibit Acute Inflammation", AMERICAN JOURNAL OF PATHOLOGY, vol. 138, 1 May 1991 (1991-05-01), pages 1097 - 1101, XP055490383 (B1)

TOSHIYUKI OGATA ET AL: "Anti-IL-6 receptor antibody does not ameliorate radiation pneumonia in mice", EXPERIMENTAL AND THERAPEUTIC MEDICINE, vol. 4, no. 2, 1 August 2012 (2012-08-01), GR, pages 273 - 276, XP055490373, ISSN: 1792-0981, DOI: 10.3892/etm.2012.582 (B1)

WO-A1-2009/148148 (B1)

ZANGARI MAURIZIO ET AL: "Immunomodulatory drugs in multiple myeloma.", EXPERT OPINION ON INVESTIGATIONAL DRUGS NOV 2005, vol. 14, no. 11, November 2005 (2005-11-01), pages 1411 - 1418, XP002713351, ISSN: 1744-7658 (B1)

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY : AJHP : OFFICIAL JOURNAL OF THE AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 1 AUG 2008, vol. 65, no. 15, 1 August 2008 (2008-08-01), pages 1413 - 1418, ISSN: 1535-2900 (B1)